WOODROW ADAM (VP & Chief Commercial Officer) sold 8.0% of their position (39.99K shares) of PARATEK PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $172.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/15/2021ACC: 0000904454-21-000838
Officer· VP & Chief Commercial Officer
Since Oct 2018
-39.99K
Net shares
Net seller
$172.8K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
39.99K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−6.42K
Price / share
$4.42
Trade value
$28.39K
% of position
1.3%
12/13/2021
501.32K→494.90K
Common Stock
Direct
Shares
−10.95K
Price / share
$4.37
Trade value
$47.83K
% of position
2.2%
12/14/2021
495.90K→484.95K
Common Stock
Direct
Shares
−22.62K
Price / share
$4.27
Trade value
$96.60K
% of position
4.7%
12/15/2021
484.95K→462.33K
Total
Net shares
−39.99K
Net value
-$172.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/13/2021 | S · Sale | −6.42K | $4.42 | $28.39K | 1.3% | 501.32K | 494.90K |
| Common Stock Direct | 12/14/2021 | S · Sale | −10.95K | $4.37 | $47.83K | 2.2% | 495.90K | 484.95K |
| Common Stock Direct | 12/15/2021 | S · Sale | −22.62K | $4.27 | $96.60K | 4.7% | 484.95K | 462.33K |
| Total | −39.99K | -$172.82K | ||||||
Derivative Transactions0
No derivative transactions reported